Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
EquiLend’s 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
A major step toward unified trade reconciliation across securities finance NEW YORK,…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment…
Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date
August 28, 2025 17:55 ET | Source: Enovix Corporation Alternate Price Condition…
MANTRA Announces Additional $25,000,000 Minimum Funding Commitment for First of Strategic OM Token Buybacks
Backed by key investors and stakeholders the buyback will be executed transparently…
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
August 22, 2025 12:00 ET | Source: Invivyd WALTHAM, Mass., Aug. 22,…
Abivax Announces Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (637.5M)
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing…
TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities
July 24, 2025 07:00 ET | Source: TCG Labs Soleil SAN FRANCISCO,…
Tulip Innovation Obtains Additional Battery Patent Injunction against Sunwoda Group
BUDAPEST, Hungary, July 23, 2025 /PRNewswire/ -- On 17 July 2025, Tulip…
